PROTHENA CORPORATION PUBLIC LIMITED COMPANY Stock Issued During Period, Shares, New Issues
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Stock Issued During Period, Shares, New Issues of 14.50 million shares for the 0-month period ending 2012-12-20, per its 10-K filed 2014-03-07.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2014-03-07
- 2012-12-20: Stock Issued During Period, Shares, New Issues 0 month 14.50M shares.
| Period end | Stock Issued During Period, Shares, New Issues 0 month |
|---|---|
| 2012-12-20 | 14.50M shares 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |